News

media

Oct 14, 2020

Forbes

Side Effects From Chemo Can Be Devastating. This Startup Aims To Change That.

conference

Oct 9, 2020

2020 - MSTS - Preclinical Abstract

SQ3370, a Novel Technology to Locally Capture and Activate Cytotoxic Drugs, Produces Systemic Responses in Injected and Non-injected Lesions via Immune Activation

press

Jun 22, 2020

Press Release

Shasqi Demonstrates Chemistry-based Platform Produces Local and Systemic Anti-tumor Response in Preclinical Cancer Model

conference

May 29, 2020

2020 - ASCO

Local Activation via SQ3370 Enhances the Safety of Chemotherapy with Concomitant Antitumor Immune Response

conference

Apr 24, 2020

2020 - AACR

SQ3370, a Local Activation Therapy of Cytotoxic Agents, Produces Sustained Responses in Target and Distal Lesions via Immune Activation

media

Jan 7, 2020

SF Business Times

How a small biotech worked its way out of storage space during the industry's biggest conference

press

Oct 31, 2019

Press Release

Shasqi Completes $10 Million Series A Financing

media

Jul 5, 2019

Nature.com

Click chemistry targets antibody-drug conjugates for the clinic

conference

May 31, 2019

2019 - ASCO

SQ3370: Biomaterial-dependent local drug activation of systemic cytotoxic prodrugs

conference

Mar 29, 2019

2019 - AACR

SQ3370 enhances the safety of chemotherapeutics via local activation therapy

conference

Aug 1, 2018

2018 - ASCO

Local drug activation: safer cytotoxics for local tumors

press

Jul 20, 2016

Press Release

Shasqi's Local Drug Activation Technology Provides Improved Drug Efficacy with Minimal Side-effects